152 related articles for article (PubMed ID: 2232208)
1. [Monitoring of graft versus host (GVH) reaction and host versus graft (HVG) reaction].
Tanaka S; Orita K
Nihon Rinsho; 1990 Sep; 48(9):2041-7. PubMed ID: 2232208
[No Abstract] [Full Text] [Related]
2. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
3. [Immunologic bases of bone marrow transplantation].
Garrido F; López Nevot MA
An Esp Pediatr; 1989 Sep; 31 Suppl 39():100-3. PubMed ID: 2490306
[No Abstract] [Full Text] [Related]
4. Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation.
Johnson S; Qi S; Xu D; Jolicoeur M; Liu D; Barama A; Busque S; Smeesters C; Daloze P; Chen H
Microsurgery; 2003; 23(5):476-82. PubMed ID: 14558006
[TBL] [Abstract][Full Text] [Related]
5. Minor transplantation antigens: mouse models for human host-versus-graft, graft-versus-host and graft-versus-leukemia reactions.
Simpson E
Arch Immunol Ther Exp (Warsz); 1998; 46(6):331-9. PubMed ID: 9883311
[TBL] [Abstract][Full Text] [Related]
6. [Bone marrow graft: graft versus host reaction and rejection].
Fischer A; Griscelli C
Nephrologie; 1986; 7(3 Suppl):1-4. PubMed ID: 3534616
[TBL] [Abstract][Full Text] [Related]
7. What determines who develops graft-versus-host disease: the graft or the host (or both)?
Gale RP; Horowitz MM; Butturini A; Barrett AJ; Kolb HJ
Bone Marrow Transplant; 1992 Aug; 10(2):99-102. PubMed ID: 1525613
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
9. Bone marrow transplantation and graft-versus-host disease.
Powles RL
Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
[No Abstract] [Full Text] [Related]
10. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic memory T cell response.
Chen BJ
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):20-2. PubMed ID: 19418623
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic aspects of bone marrow transplantation].
Cesbron A; Moreau P; Muller JY
Rev Fr Transfus Hemobiol; 1993 Jul; 36(4):339-73. PubMed ID: 8357446
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host disease: a surge of developments.
Riddell SR; Appelbaum FR
PLoS Med; 2007 Jul; 4(7):e198. PubMed ID: 17622190
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
15. [Bone marrow transplantation: unrelated donors are good but the risk of graft versus host reaction is increased].
Ringdén O
Lakartidningen; 1991 Oct; 88(40):3259-60. PubMed ID: 1943332
[No Abstract] [Full Text] [Related]
16. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
[No Abstract] [Full Text] [Related]
17. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K
Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
[TBL] [Abstract][Full Text] [Related]
18. Prevention of graft-versus-host disease on an individual basis.
Aschan J; Ringdén O; Andström E; Ljungman P; Remberger M
Transplant Proc; 1994 Jun; 26(3):1823-4. PubMed ID: 8030155
[No Abstract] [Full Text] [Related]
19. Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
Johnsen HE
N Engl J Med; 1993 May; 328(20):1497-8. PubMed ID: 8479479
[No Abstract] [Full Text] [Related]
20. [Allogenic reaction, a model of autoimmunity].
Goldman M; Abramowicz D
Rev Prat; 1994 Jan; 44(1):53-6. PubMed ID: 8178059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
